Your browser doesn't support javascript.
loading
First patient exceeding 5-year complete remission after 225Ac-PSMA-TAT.
Rathke, Hendrik; Bruchertseifer, Frank; Kratochwil, Clemens; Keller, Hanno; Giesel, Frederik L; Apostolidis, Christos; Haberkorn, Uwe; Morgenstern, Alfred.
Afiliação
  • Rathke H; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany. hendrik.rathke@med.uni-heidelberg.de.
  • Bruchertseifer F; European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
  • Kratochwil C; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
  • Keller H; Urology Center Mannheim, Mannheim, Germany.
  • Giesel FL; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
  • Apostolidis C; Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Haberkorn U; European Commission, Joint Research Centre, Directorate for Nuclear Safety and Security, Karlsruhe, Germany.
  • Morgenstern A; Department of Nuclear Medicine, Heidelberg University Hospital, INF 400, 69120, Heidelberg, Germany.
Eur J Nucl Med Mol Imaging ; 48(1): 311-312, 2021 01.
Article em En | MEDLINE | ID: mdl-32468252
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Actínio / Compostos Heterocíclicos com 1 Anel Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Actínio / Compostos Heterocíclicos com 1 Anel Idioma: En Ano de publicação: 2021 Tipo de documento: Article